Akebia Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA), a biopharmaceutical company focused on kidney disease, has announced its participation in two upcoming investor conferences in September 2024. The company's executives will attend the Wells Fargo Healthcare Conference in Boston from September 4-6 and the H.C. Wainwright 26th Annual Global Investment Conference in New York from September 9-11.

CEO John Butler will present at both events:

• Wells Fargo Healthcare Conference: Friday, September 6 at 9:30 a.m. EST
• H.C. Wainwright Global Investment Conference: Monday, September 9 at 10:30 a.m. EST (fireside chat)

Webcasts of both presentations will be available through Akebia's investor relations website for approximately 90 days following the conferences.

News Market Reaction – AKBA

+1.31%

+1.31% Session move

In the trading session that priced this news, AKBA gained 1.31%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Aug. 26, 2024 /PRNewswire/ -- Akebia Therapeutics^®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that its executives will participate in two investor conferences in September: Wells Fargo Healthcare Conference on September 4-6, 2024 in Boston and H.C. Wainwright 26^th Annual Global Investment Conference on September 9-11, 2024 in New York.  

Wells Fargo Healthcare Conference
John Butler, Chief Executive Officer, will present on Friday, September 6 at 9:30 a.m. EST.

H.C. Wainwright Global Investment Conference
Mr. Butler will participate in a fireside chat on Monday, September 9 at 10:30 a.m. EST.

A webcast of each presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com following the conferences. A replay of the webcast will also be available for approximately 90 days following the conference through the Investors section of Akebia's website at https://ir.akebia.com.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-upcoming-investor-conferences-302229594.html

SOURCE Akebia Therapeutics

FAQ

When is Akebia Therapeutics (AKBA) presenting at the Wells Fargo Healthcare Conference in 2024?

Akebia Therapeutics (AKBA) CEO John Butler will present at the Wells Fargo Healthcare Conference on Friday, September 6, 2024, at 9:30 a.m. EST.

What investor conferences is Akebia Therapeutics (AKBA) attending in September 2024?

Akebia Therapeutics (AKBA) is attending two investor conferences in September 2024: the Wells Fargo Healthcare Conference in Boston from September 4-6, and the H.C. Wainwright 26th Annual Global Investment Conference in New York from September 9-11.

How can investors access Akebia Therapeutics' (AKBA) conference presentations?

Investors can access webcasts of Akebia Therapeutics' (AKBA) conference presentations through the 'Investors' section of the company's website at https://ir.akebia.com. The webcasts will be available for approximately 90 days following the conferences.

What is the focus of Akebia Therapeutics (AKBA) as a biopharmaceutical company?

Akebia Therapeutics (AKBA) is a biopharmaceutical company focused on improving the lives of people impacted by kidney disease.